Ibu & Bladder transitional cell carcinoma
100.0%
of users reported Bladder transitional cell carcinoma
64.3%
also reported Severe reaction
100.0%
are women
Most common medical consequences
Severe reaction
64.3%
Hospitalization
35.7%
Have you experienced any negative side effects from this medication?
Ibu: general information
Most common side effects (1)
Most commonly affected ages
60 - 69 years
100.0%
Stay safe!
Get the latest drug safety information, personalized and delivered straight to your inbox